NONPROFIT, NONPARTISAN PLATFORM OF ACCURATE SCIENCE-BASED SOLUTIONS TO COVID-19

FemtoDx

Business Name:
FemtoDx
Business Genre:
Business Description:

Company focus is home-based monitoring of cardiovascular diseases with a panel of clinically validated biomarkers [1]. They aim to improve the quality of point-of-care tests to meet needs of medical professionals. They collaborate with universities and hospitals in LA and partner with leading product development and manufacturing companies [1].

City:
Beverly Hills
State:
CA
Country:
USA
Data/Evidence of Effectiveness:
N/A
Complimentary Products Needed to Perform Test:
N/A
Setting of Care:
At home [2]
Current Status / Clinical Development Stage / Expected Milestones:
In development/proof of concept [3]
LOD:
N/A
Funding & Ownership :
Private [4] Estimated to be less than $1M a year [5].
Business Model:
They are a medical device company specializing in Semiconductor Physics, Biochemistry, Microfluidics, Si Devices, and Clinical Chemistry [4].
IP:
N/A
History & Origins :
Company was founded in 2014 [4]. Originated from years of academic research. FemtoDx provides the resources to solve some of the most challenging problems in healthcare. They perform product design, development, and manufacturing in partnership with the country’s leading companies [2]. It appears that their specialty is creating devices to detect heart failure and stroke before they occur [1].
Date EUA Issued:
N/A – Still in development [3]
Sources:
[1] https://femtodx.com/ [2] https://femtodx.com/news/2020/3/31/femtodx-launches-rapid-at-home-test-development-for-covid-19 [3] https://www.finddx.org/covid-19/pipeline/?section=molecular-assays#diag_tab [4] https://www.linkedin.com/company/femtodx/about/ [5] https://www.owler.com/company/femtodx
Organization:
“Raj Mohanty, PhD- CEO, Founder & Board Member Shyam Erramilli, PhD- Founder, SAB Chairman Sanjiv Taneja- Chief Operating Officer David Weaver, PhD- Chief Scientific Officer Stan Lapidus- Senior Advisor Carla Sivak- Regulatory & Quality Affairs Hiroo Awano- Corporate Development Robert Dinello, PhD- Director of Assay Development Patrick Anquetil, PhD- Board Member Rahul Baldota- Board Member Steve Steinhubl, MD- Advisor Sudhakar Pamarti, PhD- Advisor [1].”
No. Tests Per Day:
N/A
Time to Result:
Less than 5 minutes [2]
Test Sample Type:
N/A
Technology Overview:
At home test that is connected to the cloud [2]
Testing Type:
Presumably PCR, but information is limited since it’s still in development
Test Category:
RT-PCR
Test Name:
COVID-19 Rapid Home Nucleic Acid Test
Clinical Application & Need:
At home use – detection of infection [2]
Age of Company:
2014 [4]

Send Message to listing owner

Leave A Reply